Showing results (191-200 of 205) with videos related to

Sort By:
Pageof 21
JTO Clinical and Research Reports|November 25, 2022
A Randomized Phase 2 Trial of Nivolumab Versus Nivolumab-Ipilimumab Combination in EGFR-Mutant NSCLCGillianne G Y Lai, Jia Chi Yeo, Amit Jain, et al.
JHEP Reports : Innovation in Hepatology|April 8, 2026
Multiomics and multi-region spatial transcriptome analysis reveal cellular networks and pathways associated with HCC recurrenceVeerabrahma P Seshachalam, Ita N Sari, Kane Toh, et al.
Nature Communications|March 18, 2022
Trajectory of immune evasion and cancer progression in hepatocellular carcinomaPhuong H D Nguyen, Martin Wasser, Chong Teik Tan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 25, 2019
Clonal MET Amplification as a Determinant of Tyrosine Kinase Inhibitor Resistance in Epidermal Growth Factor Receptor-Mutant Non-Small-Cell Lung CancerGillianne G Y Lai, Tse Hui Lim, John Lim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 15, 2020
Sensitive Detection of Minimal Residual Disease in Patients Treated for Early-Stage Breast CancerHeather A Parsons, Justin Rhoades, Sarah C Reed, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 15, 2021
Integrative Profiling of T790M-Negative EGFR-Mutated NSCLC Reveals Pervasive Lineage Transition and Therapeutic OpportunitiesKhi Pin Chua, Yvonne H F Teng, Aaron C Tan, et al.
Nature Cell Biology|April 24, 2023
PBRM1-deficient PBAF complexes target aberrant genomic loci to activate the NF-κB pathway in clear cell renal cell carcinomaXiaosai Yao, Jing Han Hong, Amrita M Nargund, et al.
Cancer Discovery|January 14, 2026
Mutational Signatures and Clonal Hematopoiesis in Intestinal Metaplasia across Countries with Varying Stomach Cancer IncidenceKie Kyon Huang, Takeshi Hagihara, Benedict Shi Xiang Lian, et al.
Pageof 21